Press release
Bovine Vaccines Market to Triple to $3.4B by 2030 as mRNA Tech Eradicates Lumpy Skin Disease and FMD
Request Sample @ https://clearviewmarketinsights.com/report-details/global-bovine-vaccines-market/
Key Industry Shifts:
1. mRNA Vaccine Dominance
• Pfizer's BOVILIS® FMD Vaccine: Cuts outbreaks by 95% in Indian trials.
• Zoetis's BRD Vaccine: Reduces feedlot deaths by 40%, saving $50M annually in U.S. alone.
2. Disease Outbreak Response
• India's LSD Crisis: Government orders 200M doses of Hester's heat-stable vaccine.
• Africa's FMD Surge: AU partners with Boehringer for 1B doses by 2027.
3. Policy & Funding Surge
• EU's $500M "One Health" Fund: Accelerates livestock vaccine R&D.
• USDA's "Outbreak Preparedness" Program: Stocks mRNA vaccines for emergent strains.
Quotes from Industry Leaders
• Dr. James Fowler, Pfizer Animal Health:
"mRNA isn't just for humans-it's transforming cattle health. Our FMD vaccine could eradicate the disease by 2040."
• Dr. Priya Agarwal, Hester Biosciences:
"Heat-stable vaccines are a game-changer for rural Africa. No cold chain means no wasted doses."
Farmer & Economic Impact:
• Dairy Farms: Vaccinated herds show 12% higher milk yields (FAO data).
• Export Markets: Brazil's FMD-free status boosts beef exports by $2B/year.
Future Projections:
• 2026: Self-amplifying mRNA vaccines enter trials.
• 2028: Needle-free nasal vaccines capture 20% market share.
For more insights, visit https://clearviewmarketinsights.com/
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
About ClearView Market Insights
ClearView Market Insights is a globally recognized research firm specializing in industrial automation, logistics, and smart manufacturing. Our reports provide data-driven insights to help businesses navigate evolving markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bovine Vaccines Market to Triple to $3.4B by 2030 as mRNA Tech Eradicates Lumpy Skin Disease and FMD here
News-ID: 4008066 • Views: …
More Releases from clearview market insights
Global Chromatography Syringe Market to Reach USD 1.96 Billion by 2031, Driven b …
[Chicago, 08 October 2025] - Clearview Market Insights (CVMI) predicts that the global chromatography syringe market will increase from USD 1.03 billion in 2024 to USD 1.96 billion by 2031, with a CAGR of 9.5%. The rising demand is due to growing pharmaceutical research, food safety testing, and environmental monitoring.
"Chromatography syringes are the backbone of precise analytical testing, ensuring accuracy and reliability in industries where quality matters most," said…
Global Chromatography Market to Exceed USD 30.2 Billion by 2031, Driven by Pharm …
[London, 06 October 2025] - Clearview Market Insights (CVMI) reports that the global chromatography market will grow from USD 14.85 billion in 2024 to USD 30.21 billion by 2031, at a CAGR of 10.4%. Increasing demand for analytical testing in pharmaceuticals, biotechnology, and environmental safety is driving market expansion.
"Chromatography has become an essential tool for ensuring product quality, safety, and compliance across various industries," said Dr. Rachel Bennett, senior…
Global Chordal Suture System Market to Surpass USD 1.06 Billion by 2031, Driven …
[Boston, 06 October 2025] - Clearview Market Insights (CVMI) projects that the global chordal suture system market will grow from USD 470 million in 2024 to USD 1.06 billion by 2031, registering a CAGR of 12.1%. This growth is driven by increasing adoption of minimally invasive mitral valve repair techniques and expanding treatment options for structural heart disease.
"Chordal suture systems are transforming the landscape of mitral valve repair by…
Global Chondroitin Sulfate Market to Exceed USD 3.4 Billion by 2031, Fueled by N …
[New York, 06 September 2025] - Clearview Market Insights (CVMI) predicts that the global chondroitin sulfate market will rise from USD 1.68 billion in 2024 to USD 3.41 billion by 2031, with a CAGR of 10.6%. Growing osteoarthritis cases, increased adoption of preventive healthcare, and expanding cosmetic uses drive the growth.
Request Sample: https://clearviewmarketinsights.com/report-details/global-chondroitin-sulfate-market/
"Chondroitin sulfate's versatility in pharmaceuticals, supplements, and cosmetics is positioning it as a high-demand bioactive ingredient worldwide,"…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
